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Antisaccades are thought to involve higher level inputs from neural centers involved 
in rapid eye movement inhibition and control. Previous work has demonstrated that 
performance on the antisaccade task can help in the assessment of injury in acute and/
or chronic mild traumatic brain injury (mTBI). In this exploratory study, we performed 
cross-sectional and longitudinal comparisons of rapid eye movement, followed by cor-
relations of antisaccade performance with assessments of symptom burden, diffusion 
tensor imaging, and a neuropsychological test of response inhibition. Significant deficits 
in antisaccade median latency, F(2, 31) = 3.65, p = 0.04 and prosaccade error mean 
duration, F(2, 31) = 3.63, p = 0.04 were found between patient groups and controls: the 
former was correlated with loss of white matter integrity in the splenium of the corpus 
callosum in acute mTBI, rho = 0.90, p = 0.0005. Furthermore, increased antisaccade 
median latency was also correlated with poor performance on an executive functioning 
task, r2 = 0.439, p = 0.03, and greater symptom burden, r2 = 0.480, p = 0.02 in the 
acute mTBI patients. Our preliminary research suggests that the antisaccade task could 
be useful as a neurological marker for mTBI and concussion, but more work is required.
Keywords: antisaccade, concussion, mild traumatic brain injury, diffusion tensor imaging, executive function, 
corpus callosum, symptom burden
inTrODUcTiOn
Few objective assessment tools exist to aid the clinician in the assessment of mild traumatic brain injury 
(mTBI) and concussion from both an emergency standpoint and in clinic follow-up. Furthermore, 
little is known about the relationship of symptom load to measures like white matter integrity and 
other objective measures of brain function. Comprehensive scales have been developed that sys-
tematically seek to identify the collective cognitive, emotional, and somatic symptoms after mTBI 
FigUre 1 | an illustrated schematic of the antisaccade task. 
Abbreviations: PS = prosaccade; AS = antisaccade.
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of all etiologies, but an objective test would be an advantage for 
assessment. Executive functioning deficits after TBI encompass 
domains such as attention (1), working memory (2, 3), response 
inhibition, and other cognitive subsystems involved in the control 
and regulation of behavior, due to frontal lobe susceptibility to 
injury. The Stroop color and word test is a common measure of 
a specific type of executive functioning known as interference 
control.
For mTBI patients, traumatic axonal injury is thought to be 
a result of damage to the neurofilament organization and axo-
lemma (4). Diffusion tensor imaging (DTI) findings after mTBI 
(4) have found that the frontal association white matter tracts, 
namely, the anterior corpus callosum, superior longitudinal 
fasciculus, anterior corona radiata, and uncinate fasciculus were 
common areas of white matter damage in mTBI. Significant 
effect sizes of FA reductions and MD increases have been found 
across studies in a meta-analysis of the corpus callosum (5). The 
corpus callosum, in particular, is important for many cognitive 
functions; it is involved in bilateral information transfer and 
coordination between the prefrontal cortices (6). Croall et  al. 
conducted a longitudinal study in mild/moderate TBI patients 
who were scanned acutely and returned for a chronic assessment, 
correlating structural integrity with neuropsychological perfor-
mance, and found significant changes in fractional anisotropy 
and mean diffusivity in acute mTBI patients (on average 6 days 
post-mTBI) compared to controls in the ascending and posterior 
corpus callosum, respectively (7). However, this study did not 
investigate inhibitory control processes. Kinnunen et  al. found 
significantly lower FA in the mTBI compared to control groups in 
the corpus callosum and several other areas (8). MD was elevated 
in the mTBI groups compared to the control groups in similar 
areas, including the internal and external capsule. The authors of 
this study did not find significant correlations between executive 
functioning and FA, but there was a correlation between higher 
mean diffusivity in the white matter of the superior temporal 
areas and worse performance on executive functioning tasks. To 
our knowledge, there does not seem to be any studies directly 
correlating a subset of executive functioning, namely interference 
control performance to FA/MD changes in both acute mTBI and 
persistent post-traumatic symptom (PTS) patients at the same 
time.
It is important to understand the relationships of symptom 
burden and executive functioning to antisaccade performance 
in acute mTBI and PTS, but antisaccades’ relationship to 
DTI has not been investigated. Specifically, we do not know 
whether the major white matter pathways damaged in mTBI 
(corpus callosum, superior longitudinal fasciculus, uncinate 
fasciculus, and anterior corona radiata) are necessarily com-
mon to the white matter pathways necessary for antisaccade 
performance (projections from the dorsolateral prefrontal 
cortex, anterior cingulate cortex to the superior colliculus) in 
mTBI or are related to their function in some way. One focus of 
this study will be identifying correlations with significant dif-
ferences in saccade performance variables. There is no literature 
investigating whether there is any correlation between acute 
structural integrity (measured by DTI) and performance on 
the antisaccade.
Recent work has advocated the use of rapid eye movements in 
the assessment of TBI (9). Generating a saccadic eye movement 
requires coordinated action between many control centers, and 
the neurophysiology involved has been well defined after dec-
ades of study (10–12). Completing the antisaccade task requires 
making a rapid eye movement to the mirror-opposite location 
to where a saccade target appears, relative to a central fixation 
point as soon as possible (Figure 1). The cognitive demands of 
the color-word component of the Stroop color and word test 
are similar to those of the antisaccade. Participants must give 
a verbal response indicating the color ink in which the word is 
printed, but not what the word says. The word stimulus interferes 
with the correct verbal response, in much the same way that the 
prosaccade error target interferes with the correct antisaccade 
response. Performance on these two tasks should be correlated to 
some extent. Successful completion of interference tasks requires 
well-functioning response inhibition control systems from the 
higher cognitive systems in the frontal and parietal areas of the 
brain, which may be common to both neuropsychological and 
antisaccade performance. For the antisaccade task specifically 
(13), it is thought that the higher cortical regions in the frontal 
(14) and parietal lobes, namely the frontal eye fields (10, 15), 
supplementary eye fields, dorsolateral prefrontal cortex (10, 
15, 16), posterior parietal cortex, and parietal eye field (10) are 
responsible for inhibiting the reflexive prosaccade error (17).
Research has suggested that mTBI patients exhibit deficits in 
saccadic generation and difficulty inhibiting a planned saccadic 
eye movement within 2 days of injury (18). Antisaccade latency 
returns to normal after 1 week post-mTBI (19, 20), but accuracy 
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differences have been documented up to few months postinjury 
(20). Some studies have shown that antisaccade accuracy appears 
to be impaired in the acute stages, with patients making more 
errors than controls (19–21); others indicate better performance 
(22). Only one study was found to relate acute antisaccade perfor-
mance to neuroimaging, and the focus was mainly on functional 
performance (21). Functional hyperactivation was observed in 
the cerebellum and V5/V1 cortical areas, but not the frontal areas 
during the antisaccade task, contrary to their initial predictions. 
Antisaccade performance in TBI patients with chronic symptoms 
several years after injury has been investigated (23). Kraus et al. 
found significant increases in the number of prosaccade errors 
(saccade toward stimulus) and latency (in the overlap condition) 
in the antisaccade task in TBI patients compared with healthy 
controls but no differences between TBI patients of different 
severities (mTBI versus moderate/severe TBI). This suggested 
that there was low specificity of the antisaccade task in differenti-
ating between mTBI and more severe head injuries in the chronic 
stages, but their use of electrooculography limits the precision of 
antisaccade measurement compared to the chip-based measure-
ment methods.
Studies to date in PTS patients have not correlated antisac-
cade performance with gold standard structural neuroimaging. 
A useful antisaccade marker should be furthermore related to the 
symptoms that patients are experiencing. Heitger et al. correlated 
saccade deficiencies in the acute phase with quality of life in the 
PTS phase (24). Importantly, oculomotor performance (including 
antisaccade tasks as well as other saccade test results) 1 week after 
injury was significantly predictive of greater symptom burden on 
the Rivermead Post-Concussive Symptoms Questionnaire (RPQ) 
and certain domain scores of the Short-Form-36 questionnaire 
at 3 and 6 months following mTBI. This study expanded upon 
Heitger et al.’s earlier results but performed correlations within 
the same visit, similar to their later work (25) but with a greater 
number of antisaccade trials per participant.
Previous work has correlated antisaccade performance with 
a cluster of executive functioning tests and found a significant 
negative correlation between antisaccade latency and a pooled 
executive functioning score for a sample of TBI subjects of all 
severities – only considering the mTBI patients, they found trends 
(23). Also important is their use of pooled scores for their cor-
relational analyses, which may have masked direct correlations 
between specific executive functioning tests and antisaccade 
performance.
Symptom assessment, neuroimaging, and neuropsychologi-
cal assessment are helpful but insufficient for diagnosing mTBI. 
Rapid eye movements can be measured after injury, either alone 
or as an adjunct to the measures previously discussed. Although 
we have reviewed several eye movements that may be useful for 
more severe disorders of consciousness inflicted by moderate 
to severe TBI (26), more information is needed to determine 
whether antisaccades are related to common assessment metrics 
in mTBI, and this is a gap in the current literature.
Our primary aim is to confirm whether components of the 
antisaccade performance are affected by acute mTBI and those 
with PTS when compared to controls, hypothesizing that anti-
saccade performance should be most affected early after acute 
mTBI, it should improve over time, and it should be worse in 
PTS individuals. Our secondary aim is to examine neuroimaging 
of these patients, hypothesizing there would be lower fractional 
anisotropy and increased mean diffusivity in acute and PTS 
patients’ scans compared to control patients’ scans in white mat-
ter regions of interest (ROIs) due to diffuse axonal injury after 
mTBI. Specific areas of interest included the corpus callosum 
and all its component areas (genu, body, and splenium), uncinate 
fasciculus, superior longitudinal fasciculus, internal capsule (part 
of the anterior corona radiata). Importantly, we hypothesized that 
antisaccade performance would be correlated with FA and MD 
in these white matter areas. In our final aim, we hypothesized 
that patients with poor antisaccade performance would also show 
poor performance in neuropsychological tests of response inhi-
bition since antisaccades involve inhibitory processes mediated 
by the frontal and prefrontal cortices. Further, we hypothesized 
that measures of symptom burden improve after mTBI, and the 
former would be correlated to antisaccade performance.
MaTerials anD MeThODs
All participants provided written informed consent before being 
prospectively enrolled in the study. We screened patients who 
registered in the Emergency Department and Outpatient Head 
Injury Clinic at St. Michael’s Hospital (SMH). Healthy controls 
were recruited from word of mouth to the friends and relatives of 
the participants. This work was part of a larger study, which was 
approved by the Research Ethics Board at SMH.
inclusion and exclusion criteria
We used the World Health Organization definition of mTBI 
(27) (see Supplementary Methods in Supplementary Material) 
with some qualifications. PTS patients sustained mTBI at least 
3 months prior to testing and reported PTS 3 months or longer 
after their injury. We included concussions within our group 
of mTBI patients. We chose to focus on mTBI and not purely 
concussion, as positive neuroimaging should not preclude 
antisaccade measurement if this tool were to be eventually used 
in the clinic environment. Inclusion criteria for the study also 
included age greater than or equal to 16 years, able to provide 
informed consent and adequate verbal English language skills. 
All participants required a structured history to rule out 
horizontal diplopia, severe loss of visual acuity and exclusion 
conditions noted below. The control group was matched to the 
patient groups based on age (±5 years), sex, and years of educa-
tion (±5 years).
Acute mTBI, PTS, and healthy control participants were 
excluded if they were medically unstable or intoxicated (by drugs 
or alcohol) at the time of recruitment, had medical comorbidities 
of multiple sclerosis, prior incisional brain surgery, prior brain 
irradiation, prior hydrocephalus, a history of stroke, early/
alcohol-related dementia, neurodegenerative disease including 
Alzheimer’s disease, and uncontrolled diabetes. In terms of 
optic pathology, participants were excluded if they had a his-
tory of eye disease (amblyopia or glaucoma) or orbital trauma 
due to the present injury. Participants were excluded from the 
saccadometry analysis if they were taking medications known to 
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interfere with saccadic eye movement function (benzodiazepines 
and antipsychotics).
Participant assessments
Acute mTBI patients were asked to come in for two visits to SMH: 
the first visit within a week of injury, and the second visit 2–4 weeks 
after the injury. Patients with PTS recruited from the head injury 
clinic were invited to SMH once to participate in all study activi-
ties. Healthy control participants who had no history of TBI were 
recruited and invited to come into SMH twice, 2–4 weeks apart. 
We attempted to minimize the latency between injury and the 
first visit. During the first visit, the participant completed an 
antisaccade task for 100 trials, a series of neuropsychological 
tests and the MRI scan if scheduling allowed. Prior to this, we 
obtained demographics information and injury characteristics 
through taking a brief history. A second assessment was carried 
out between 2 and 4 weeks after the participant’s mTBI. During 
the second assessment, we carried out the same tests as we did in 
the first assessment to assess recovery of function after mTBI on 
both neuropsychological testing and antisaccade performance. 
PTS participants conducted all neurological and neuropsycho-
logical tests, as well as the MRI on one visit.
rapid eye Movement Measurement
We used a portable research device, the Saccadometer Advanced 
from Ober Consulting. The saccade and fixation targets were 
projected onto the wall with three red low-power laser lights. 
The lights were projected onto a matte white wall 1.5–3.5 m away 
from the participant’s eyes. All saccadometry was conducted 
under darkened conditions as per a published pilot study by our 
research group (28). The saccadometer automatically adjusted for 
minor deviations in distance between the participant’s forehead 
and the distance to the wall so long as it was within the range 
defined above. It also automatically marked and excluded inter-
vening blinks.
All participants were guided through calibration and tutorial 
sessions prior to the antisaccade task. Participants who were 
myopic or hyperopic were asked to wear contacts to ensure 
corrected visual acuity for the saccade tests or were examined to 
ensure they could see all three saccadic targets clearly and with-
out horizontal diplopia before proceeding. The antisaccade task 
was preprogramed into the saccadometer by the manufacturer. 
Participants were shown a red center light, after which it jumped 
either to the left or to the right (fixed probability 50%) with 10° 
horizontal displacement. There was a fixed foreperiod of 1000 ms 
and a random foreperiod with a maximum of 1000  ms. They 
were instructed to look at the center light. When it jumped to 
the left or to the right, participants were instructed to look in the 
mirror-opposite location as accurately and quickly as they could. 
The waiting and trial break time for each saccade was 2000 and 
1000  ms, respectively. We performed the gap antisaccade task, 
in which the center light turned off before presentation of the 
antisaccade target. Each participant demonstrated understand-
ing of the expected antisaccade task before recording of the data 
started. Nine acute mTBI participants returned for their second 
visit, but antisaccade data could not be collected for one partici-
pant (n = 8).
Raw saccadometry data were transferred to a computer with 
LatencyMeter Software version 5.2. The software and integrated 
hardware automatically accounted for eye blinks and head move-
ment during its preprocessing. Saccades with latencies <50 ms 
(anticipatory saccades) and >600 ms (increased latency due to 
inattention/possible attempt at malingering) were excluded from 
the analysis, forming the lower and upper bounds of antisaccade 
latency, respectively. Saccade trials falling within these bounds 
were defined as accepted. We attempted to make a more homoge-
neous and reliable subset of trials using this method.
The antisaccade directional accuracy was operationally defined 
by the number of accepted antisaccades in the correct (anti-) 
direction for each session. After individual saccadic trials were 
screened based on the criteria above, intraparticipant median 
latencies were calculated across trials for each participant at each 
visit. The interparticipant means of these median values were 
used for statistical comparisons between groups. An analogous 
set of dependent variables were calculated for incorrect prosac-
cade errors, which fit within the defined latency range for all the 
three groups across all the visits.
neuroimage acquisition and Processing
We used a 2.4 mm × 2.4 mm × 3.0 mm voxel interleaved echo-
planar acquisition, on a 3.0-T Siemens Skyra Magnetom (204 
coil elements), with 12 non-collinear diffusion directions and 
one b1 = 0 reference scan at 3.0 mm slice thickness. The b2 fac-
tor = 1000 s/mm2. For acute patients, the majority of the MRI 
scans were conducted on the second visit (n = 9) so the neuroim-
age correlational analyses were conducted using data from this 
visit. For control participants, the majority of MRI scans were also 
conducted on the second visit (n = 7) to match the acute patients.
Diffusion MR images were preprocessed and analyzed using 
the Functional Magnetic Resonance of the Brain (FMRIB) FSL 
Toolbox (FMRIB Software Library, Release 5.0, 2012, University 
of Oxford, England on OS X 10.9) (29). Raw NIfTI images were 
inspected manually for any gross acquisition abnormalities. Scans 
that developed excessive gross distortions due to severe head 
motion or dental braces during acquisition, or incomplete scans 
were excluded from further analyses. Images were eddy-corrected 
using the EDDY program in the FSL toolbox to reduce distortion 
effects and skull-stripped using the Brain Extraction Tool (BET) 
from the FSL toolbox to exclude the non-brain voxels. Using 
FSLVIEW, each scan was manually checked for eddy correction 
and brain extraction errors. Binary masks were manually drawn 
for each scan using FSLVIEW and used for diffusion tensor fitting 
using DTIFIT. Parameters included the original eddy-corrected 
diffusion weighted image, the manually drawn binary mask, and 
the eigenvalue/eigenvector files, respectively.
Four scans could not be included in the DTI analysis. Two 
PTS participants were excluded due to severe distortion during 
acquisition of the magnetic resonance image. Two control par-
ticipants were not included in the analysis because the accom-
panying eigenvector and eigenvalue files could not be generated 
from the accompanying DTI scan and because of an adverse 
event, respectively. We used tract-based spatial statistics (TBSS) 
to generate the fractional anisotropy and mean diffusivity images 
necessary for further analysis and calculation of the ROI-based 
TaBle 1 | study participant demographic characteristics of acute mTBi, PTs, and healthy control groups.
Participant 
group
n (first 
visit)
Mean age 
(sD)
sex (M:F) education (full years from 
grade 1) mean (sD)
gcs score
Acute mTBI V1 11 36.5 (17) 
years
7:4 15.8 (5) years All 15 in Emergency Department (ED)
All 15 at recruitment
PTS V1 15 42.5 (15) 
years
5:10 14.9 (4) years 30 min post injury or later upon reassessment in ED (based on ED 
chart or clinical note describing injury): GCS 13: 1; GCS 14: 1; GCS 
15: 13. All 15 at recruitment
Healthy control 
V1
10 35.5 (21) 
years
5:5 15.4 (1) years All 15
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values. We defined white matter tracts from the Johns Hopkins 
University (JHU) DTI Atlas (30). ROI-based mean FA and MD 
values were then used in the further statistical comparisons. 
Mean diffusivity maps were generated in a similar fashion to 
fractional anisotropy, but the final processing step was completed 
using a custom TBSS script, which projected the mean diffusiv-
ity maps onto the original fractional anisotropy data in order to 
generate a skeletonized mean diffusivity map. MD ROI values 
were calculated in a similar fashion using the binarized templates 
from the JHU Atlas. This process was completed separately for 
an acute versus control comparison and a PTS versus control 
comparison.
symptom Burden and executive Function 
assessment
Participants completed the RPQ and the symptom assessment 
scale of the Sport Concussion Assessment Tool Version 3 (SCAT3). 
Participants also completed the Center for Epidemiological 
Studies – Depression (CES-D) scale to assess affective state. To 
measure executive function, a core set of tests within a larger bat-
tery was used, including the Stroop color and word test, the trail 
making test, and the phonemic fluency score from the Montreal 
Cognitive Assessment (MoCA), English Version 3. The Stroop 
color and word test was administered with modified instructions 
from Golden (1945), reviewed by Dr. Grant Killian (31).
statistical analyses
Cross-sectional antisaccade and neuropsychological testing data 
were analyzed using analysis of variance (ANOVA) with Fisher’s 
least significant difference (LSD) in post  hoc comparisons. 
Longitudinal antisaccade data were analyzed using paired t-tests. 
Neuroimaging data were analyzed using Wilcoxon rank-sum and 
Welch’s t-tests depending on the data distribution. Pearson corre-
lations were used for parametric data and Spearman correlations 
for non-parametric data. Statistical analyses were conducted in 
SAS 9.4 (SAS Institute, Inc., Cary, NC, USA) and GNU R 3.0.3 
for Windows (R-Core-Team, 2014).
resUlTs
Participant characteristics
Basic demographic characteristics of our participant groups are 
in Table 1, and more information is in Supplementary Table S1 
in Supplementary Material. A significant proportion (64%; n = 7) 
of the acute mTBI group had a history of previous concussion or 
head injury, and about half had comorbid medical conditions, 
such as bone, cardiovascular, respiratory, or renal disease. About 
64% (n = 7) of the acute group needed corrected vision due to 
myopia or hyperopia. The PTS group had their single visit a 
median of 8.2 months after their mTBI. A third of the PTS patients 
endorsed a history of previous concussion or head injury; about 
half (n = 8) had comorbid medical conditions.
antisaccade latency and error Duration is 
Detrimentally affected after injury
Saccadometry data are in Table  2, and more details are in 
Supplementary Tables S2 and S3 in Supplementary Material. 
There was a significant omnibus difference on median antisaccade 
latency, F(2, 31) = 3.65, p = 0.04. Post hoc LSD comparisons sug-
gested that acute mTBI participants [mean = 278.36 (SD = 28.8)] 
and PTS participants [272.86 (26.1)] had greater latency than 
the control group [241.17 (45.2)]. Figure  2A illustrates this 
result. There was a significant overall difference in mean error 
duration, F(2, 31) = 3.63, p = 0.038. Post hoc LSD comparisons 
suggested that acute mTBI participants [54.07 (11.3)] had 
greater error duration than the PTS group [45.96 (3.99)] and the 
control group [45.73 (9.10)]. Figure 2B illustrates this finding. 
Cross-sectional comparisons on the first visit between acute 
mTBI, PTS, and control groups were not significant for number 
of accepted antisaccades, antisaccade latency, mean duration, 
mean amplitude, and mean peak velocity. There were no sig-
nificant differences within the acute participants between the 
first and second visits on all antisaccade performance metrics. 
In healthy controls, the error median latency was significantly 
greater in the first visit [189.31 (40.18)] compared to the second 
visit [168.38 (24.59)] [t(7) = 3.155, p = 0.016]. Other antisaccade 
performance metrics were not significant between the two visits 
of control participants.
Diffusion Tensor imaging identified 
correlations with antisaccades
A significant positive relationship was identified between the 
mean diffusivity in the splenium of the corpus callosum and 
the median antisaccade latency at the second visit for acute 
mTBI patients [Rho (8) =  0.9048, p =  0.00045] (Figure  3A). 
There was a significantly greater mean diffusivity in the acute 
(median, Mdn  =  0.000805) group compared to the control 
group (Mdn = 0.000766) in the splenium of the corpus callosum 
(p = 0.03112). There was a significantly lower mean diffusivity in 
the PTS (M = 0.000743) group compared to the control group 
FigUre 2 | antisaccade differences between study groups. Graphs of 
(a) antisaccade latency performance and (B) error duration across 
participant groups. Acute mTBI and PTS groups had significantly greater 
antisaccade median latency than the control group. The acute mTBI group 
had greater error duration than the PTS and control groups. Error bars are 
±SEM.
TaBle 2 | cross-sectional comparisons of antisaccade performance in 
the first visit.
Mean (sD) acute 
mTBi 
visit 1
PTs 
visit 1
healthy 
control 
visit 1
results
N 11 14 9
Antisaccade 
number accepted
51.9 
(25.3)
55 
(21.6)
72.2 (26.6) F(2, 31) = 2.01, 
p = 0.15
Antisaccade 
median latency 
(ms)
278.36 
(28.8)
272.86 
(26.1)
241.17 
(45.2)
F(2, 31) = 3.65, 
p = 0.04
Post hoc: 
acute > control 
(confidence limits 
7.05, 37.20), 
PTS > control 
(−60.34, −3.04)
Antisaccade mean 
duration (ms)
85.12 
(36.0)
68.33 
(32.5)
63.45 
(17.2)
F(2, 31) = 1.46, 
p = 0.25
Antisaccade mean 
amplitude (°)
15.48 
(5.98)
13.04 
(6.14)
12.58 
(5.36)
F(2, 31) = 0.75, 
p = 0.48
Antisaccade mean 
peak velocity (°/s)
387.46 
(154.38)
440.92 
(259.76)
437.61 
(143.88)
F(2, 31) = 0.25, 
p = 0.78
Error median 
latency (ms)
178.64 
(1.36)
182.29 
(28.9)
193.17 
(39.3)
F(2, 31) = 0.69, 
p = 0.51
Error mean 
duration (ms)
54.07 
(11.3)
45.96 
(3.99)
45.73 
(9.10)
F(2, 31) = 3.63, 
p = 0.038
Post hoc: 
acute > PTS (1.29, 
14.9), acute > control 
(0.73, 15.6)
Error mean 
amplitude (°)
9.92 
(1.47)
9.36 
(2.09)
8.41 (2.05) F(2, 31) = 1.58, 
p = 0.2214
Error mean peak 
velocity (°/s)
432.53 
(75.95)
470.90 
(249.19)
406.85 
(101.53)
F(2, 31) = 0.39, 
p = 0.6808
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(M = 0.000761) in the corticospinal tract (p = 0.04917). There 
were no other significant differences between groups in fractional 
anisotropy and in mean diffusivity. There were no significant cor-
relations between right corticospinal tract mean diffusivity and 
antisaccade median latency/error duration for PTS patients at 
their only visit.
symptom Burden and executive 
Functioning correlated with antisaccades
There was a significant positive correlation between antisaccade 
median latency and SCAT3 symptom severity score, r2 = 0.480, 
p = 0.02 in the acute mTBI patients at their first visit (Figure 3B). 
There was a significant negative correlation between antisaccade 
median latency and stroop color-word score, r2 = 0.439, p = 0.03 
in the acute mTBI patients at the first visit (Figure 3C). There was 
a significant difference between groups on the Stroop color-word 
score, F(2, 33) = 6.59, p = 0.0039. Post hoc comparisons indicated 
that acute mTBI participants [39.7 (9.7)] scored worse compared 
to controls [52.1 (12.0)] and PTS participants [39.1 (7.1)] also 
scored worse than controls.
SCAT3 total score F(2, 33) = 30.8, p < 0.0001 was significantly 
greater in the acute mTBI group [13.3 (4.76)] and PTS group 
[16.3 (5.91)] compared to controls [1.3 (2.26)]. SCAT3 symptom 
severity score F(2, 33) = 13.9, p < 0.0001 was also significantly 
different between all the three groups in ascending order, start-
ing with controls [2.3 (3.95)], then to acute mTBI patients [31.18 
(21.6)], and then to PTS patients [52.87 (31.0)]. Analysis of RPQ 
total score indicated significant differences in symptom reporting 
cross-sectionally between participant groups, F(2, 33) =  40.5, 
p < 0.0001. All the three groups were significantly different from 
one another in ascending order, starting with controls [1.3 (3.47)], 
then acute mTBI [18 (10.3)], and finally PTS [40.53 (14.0)]. Stroop 
color performance was  significantly impaired between groups 
F(2, 33) = 4.67, p = 0.0164. Post hoc comparisons indicated that 
acute mTBI participants [75.8 (17.3)] scored worse compared to 
controls [89 (13.6)] and PTS participants [72.4 (10.2)] also scored 
worse than controls.
FigUre 3 | antisaccade correlations with study measures. (a) Significant positive correlation at second visit between acutely injured white matter integrity in 
the corpus callosum splenium and antisaccade latency performance; (B) significant positive correlation at first visit between SCAT3 symptom severity score and 
antisaccade median latency performance in acute mTBI patients; (c) significant negative correlation at first visit between Stroop color-word score and antisaccade 
latency in acute mTBI patients.
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DiscUssiOn
Main Finding
The main finding of this study is that there is a distinguishing char-
acteristic of the antisaccade, which is significantly affected after 
injury, and that antisaccade performance is correlated with white 
matter integrity, response interference, and symptom burden.
antisaccade latency and error Duration is 
Detrimentally affected after injury
The median antisaccade latency at the first visit was significantly 
greater in the patient groups compared to controls, but we found no 
significant difference between acute mTBI and PTS groups at the 
first visit. Our analyses suggested that antisaccade latency may be 
a good metric for distinguishing injury from non-injury, although 
the heterogeneity of mTBI and persistence of symptoms remain 
a problem. To some extent, this supports what has been found in 
the literature in cross-sectional comparisons between injury and 
control groups. Heitger et  al. identified significant increases in 
antisaccade latency in acute mTBI groups within 1 week of injury 
compared to control groups (20), and Williams et al. also identified 
similar greater antisaccade latency in severely injured TBI patients 
compared to controls (32). There was also a greater spread in latency 
scores within the control group compared to the injury groups in 
our results. This could mean that there is a natural variation or 
normal range of antisaccade latency in our control sample (similar 
to a normal range of blood pressure or body weight in humans). 
There are also numerous other factors like attention and alertness 
level, which may affect performance on the antisaccade task. This 
is important to investigate further in future studies. Overall, as the 
antisaccade task involves response inhibition, increased latency in 
the antisaccade task may reflect greater cortical processing time 
needed to generate the correct oculomotor command. This finding 
was in line with our initial hypotheses.
There was also a significant omnibus group-wise difference in 
mean duration of their error trials, with the acute mTBI participants 
exhibiting greater duration than the PTS and control participants. 
The duration of a saccade is related to its amplitude and veloc-
ity. We found that the average amplitude for all three participant 
groups were larger than the target amplitude of 10° on the correct 
antisaccade responses, but overall were smaller than the target 
amplitude on the prosaccade error responses. It was interesting 
that a deficit was observed in the error mean duration, but not anti-
saccade  duration. It was noted by an early reviewer that our results 
in the patient group do not conform to the typical main sequence 
relationships between amplitude and velocity. Heitger et al. (25) 
attributed their observed deficits in PTS patients in prosaccade 
and antisaccade duration to damage in subcortical processing 
(25). Their results suggest that prosaccade mean  duration can 
potentially be used to distinguish between acute mTBI and PTS.
Control participants took less time to make an error prosaccade 
toward the stimulus during the second visit compared to the first 
visit (Supplementary Material). The results suggest that some anti-
saccade variables might not be stable over several weeks, even in 
healthy controls. Further studies are needed to identify the factors 
influencing antisaccade performance. The difference in antisac-
cade median latency in the pairwise control comparisons was not 
significant, suggesting stable measurement over time on this spe-
cific antisaccade variable. The error mean duration was also similar 
between both visits in each group. Hence, not all measurements 
taken acutely are reliable indicators of change in clinical state.
Diffusion Tensor imaging identified 
correlations with antisaccades
In line with our hypotheses, we identified a significant positive cor-
relation between median latency of antisaccades at the acute mTBI 
second visit and MD in the splenium of the corpus callosum. There 
appeared to be a connection between the time necessary for inhibi-
tory processes to take place, generating a successful antisaccade, 
and integrity of this white matter bundle. This correlation did not 
hold for PTS patients. Some have attributed PTS to psychosocial 
aspects of the injury, whereas the acute manifestations are a product 
of neurobiological changes in reaction to the impact (33). The lack 
of effective correlations in PTS patients may reflect this underlying 
January 2016 | Volume 6 | Article 2718
Ting et al. Antisaccades in mTBI
Frontiers in Neurology | www.frontiersin.org
disconnect between neurological functioning and the structural 
neuroanatomy. Similar relationships between antisaccade per-
formance and corpus callosum integrity have been documented 
in patients with fetal alcohol spectrum disorder in studies where 
the patients completed antisaccade tasks as well as diffusion MRI 
using voxel-based DTI analysis methods (34). The antisaccade task 
requires much greater recruitment of cerebral resources compared 
to a simple prosaccade task. It is possible that diffuse axonal injury 
of the many connections serviced by the corpus callosum splenium 
plays a significant role in the execution of an efficient antisaccade.
The difference we found in MD of the acute group’s corpus cal-
losum splenium compared to the control group partially confirmed 
our hypothesis that there would be decreased white matter integrity 
postinjury in the corpus callosum. Significant microstructural dam-
age and change in the corpus callosum in TBI patients over time 
have been identified (35, 36). As discussed, a recent meta-analysis 
specifically focusing on the corpus callosum found that DTI analy-
sis of this area was a sensitive marker for microstructural damage 
after mild TBI (5). Our findings suggest that corpus callosum 
microstructural alterations are present several weeks after injury in 
acute mTBI patients compared to healthy controls. The finding that 
MD was significantly elevated compared to controls supports the 
hypothesis that there might be increased edema and inflammation 
in the splenium component of this critical white matter bundle.
There were no significant differences in the genu and body of 
the corpus callosum, which was surprising as previous studies 
have identified vulnerability of these areas (5). Further analysis 
stratifying the impact location for acute mTBI and PTS patients 
(i.e., frontal, temporal, parietal, or occipital) may provide some 
mechanistic explanations for the negative findings in these areas, 
and the DTI analysis as a whole. We did not find significant dif-
ferences elsewhere. However, traumatic brain injury is a complex 
biophysical process often characterized by rotational injury as well 
as blunt trauma (37). There are likely variations in the severity 
and nature of white matter injury in the mTBI patients that were 
scanned, which could be further characterized by localizing the 
area of injury and a review of the structural images for distribution 
of focal white matter hyperintensities and/or infarcts. Contrary to 
our hypothesis, there were no significant differences in fractional 
anisotropy between the acute and control groups in all the ROIs 
studied. However, FA measures a different aspect of diffusion flow 
and white matter integrity compared to mean diffusivity and fur-
ther studies are needed to examine why some differences were seen 
in MD, and why FA was left unaltered postinjury. Longitudinal 
studies of DTI have found fluctuations in mean diffusivity differ-
ences from the days to a year following injury (7). It is understood 
that FA and MD will rise and fall over time from the acute stages to 
chronic stages, and our findings may reflect these natural fluctua-
tions in the corticospinal tract. Even in the acute stages, there is 
little consensus as to whether FA and MD will increase or decrease, 
as different findings have been identified between studies (38).
symptom Burden and executive 
Functioning correlated with antisaccades
Correlational analyses identified several associations between 
antisaccade performance and symptom load/executive perfor-
mance that were meaningful. We found a positive correlation 
between antisaccade median latency and SCAT3 symptom load, 
and a negative correlation between antisaccade median latency 
and Stroop interference performance at the first visit. The first 
finding made sense in that poorer antisaccade performance was 
correlated to increased symptom burden on the SCAT3. Increased 
antisaccade latency is a disorder of saccadic initiation. The time 
required for the integration and calculation of the antisaccade 
signal reflects the time needed to process this task involving 
higher brain structures and interhemispheric connectivity (10), 
in part mediated by the corpus callosum. Intact white matter 
architecture and functioning of the higher cerebral centers are 
necessary for effective saccadic initiation and normal cognitive 
functioning. Impaired cognitive functioning and specifically an 
effective way to cope with response interference may push symp-
tom burden higher in acute mTBI and PTS patients. It remains to 
be determined why this relationship was only identified for the 
acute mTBI group and not the PTS group, even though the PTS 
group reported significantly greater symptom burden on the RPQ 
and the SCAT3 on almost every question and symptom category.
Since there was a significant negative association between 
antisaccade performance and Stroop color-word score, a poten-
tial mechanistic explanation is that antisaccade performance 
reflected this executive neurocognitive impairment, which in turn 
was associated with increased symptom burden on the SCAT3. 
Currently, there is no validated subscoring system for the symp-
tom assessment scale of the SCAT3. Future work could do factor 
analyses on the SCAT3 symptom scale to identify a stable cogni-
tive performance subscale on the SCAT3 (similar to the RPQ) and 
use this subscore to correlate with antisaccade performance and 
executive functioning. We found that task interference inhibi-
tion was impaired in acute mTBI patients with the Stroop test. 
A similar cognitive process is needed in the brain to generate an 
effective antisaccade: the participant must inhibit the easiest rapid 
eye movement, an interfering one moving toward the stimulus 
(committing a prosaccade error), and cognitively program an anti-
saccade, instead rapidly moving the eyes to the mirror-opposite 
location. The interference deficit between the acute mTBI patients 
and controls suggest the antisaccade task could potentially be a 
marker for this specific neurocognitive domain and provides a 
neuropsychological link to the larger implications of this work.
Connections have been found in past research in PTS patients, 
between antisaccade performance and executive functioning (39). 
We could not confirm this relationship in our results. This was sur-
prising, given that the level of executive functioning impairment 
in PTS (measured by the Stroop color-word score) was similar to 
the acute group. One possible explanation is that in PTS patients, 
the changes in microstructure leading to sustained impairment 
in antisaccade performance were different compared to acute 
patients. This explanation is supported by our finding that the dif-
ferences in mean diffusivity were found in the corpus  callosum in 
the acute patients, but not in the PTS patients;  likewise, significant 
MD differences were identified in the right corticospinal tract in 
the PTS patients, but not the acute patients. Thus, a difference in 
the neuroanatomy of PTS may be an explanation for the negative 
findings here. As discussed in the introduction, the most drastic 
effects of the neurometabolic cascade happen acutely after injury, 
but they can ease into permanent damage in the chronic phases. 
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Perhaps, these changes are reflected in our neuroimaging results, 
but the study’s small sample size limits our conclusions.
In terms of executive functioning, in line with our hypotheses, 
there was a significant difference between the injured and control 
groups on the Stroop color-word score, with injured participants 
covering fewer items in the same amount of time as controls 
(hence scoring more poorly). The results suggested that the 
injured groups had significantly impaired interference control as 
tested by the Stroop interference trial compared to healthy control 
groups. We did not see significant differences between the acute 
and PTS group, suggesting similar levels of response inhibition 
impairment. We found significant differences in the Stroop color 
score with poorer performance in the injury groups; there have 
been reports of impaired color score differences in patients with 
postconcussive syndrome compared to controls (40).
There were no significant differences in phonemic word flu-
ency on the MoCA, and also no significant differences on the Trail 
Making Test B score although TMT-A performance was altered. 
The finding that differences in TMT-A were observed suggested 
there are differences in psychomotor speed between groups. 
White matter structural damage may be the common denomina-
tor of deficits in psychomotor speed and the deficits observed 
in antisaccade latency performance and response inhibition, but 
more work is required.
Our work supports that antisaccade latency is related to impaired 
inhibitory functioning, diffuse axonal injury in the corpus callo-
sum, and symptom load. We confirmed significant characteristics 
of antisaccade functioning, which were affected in injury patients. 
We also identified deficits in specific types of executive function-
ing, and identified relationships between antisaccade performance 
and symptom load. Our findings indicate that it may be possible to 
distinguish between mTBI participant groups and controls using 
antisaccades, both in the acute and chronic phases. However, any 
antisaccade metric that will be used for clinical purposes needs to 
be selected carefully and must be robust.
limitations and Future Directions
We did not include a task to account for malingering on the 
neuropsychological testing and inflated symptom reporting in 
the acutely or chronically injured patients. We did not account for 
depression score and other factors that may affect the relationships 
studied (age and time since injury, for example). Furthermore, we 
did not exclude patients who had a comorbid history of post-
traumatic stress disorder (PTSD), which affects the psychological 
aspect of neurocognitive functioning and symptom burden. We 
also did not account for history of previous concussion due to 
low sample sizes. We used the latency range of 50–600 ms for our 
initial screening and identification of “accepted” saccades based 
on previous work on the step saccade task (28). However, close 
to half of the antisaccade trial responses ended up falling out of 
these boundaries, limiting the validity of our conclusions. A new 
upper and lower bound for antisaccade latencies used for this 
task may be needed. We averaged the FA and MD values over the 
whole white matter region of interest (ROI). Thus, it is possible 
that any individual differences at specific points along the tracts 
were masked. This limitation was touched upon by Niogi et al. in 
their review (4) noting the large number of participants needed to 
adequately power a ROI-based inquiry of DTI changes after mTBI. 
As reviewers noted, since computerized tomography results are 
more likely to be used for mTBI, future work may consider any 
correlations between tomography findings and PTS. Furthermore, 
this population is inherently heterogeneous and future work may 
need to account for this variability, and a sensitivity/specificity 
analysis would be very informative with a larger sample size. 
Finally, although our experimental design and timing of visits was 
adjusted to overall clinical course for recovery in mTBI patients 
and the expected course of recovery in saccadic eye movements, it 
is possible that this timeframe was not long enough for significant 
resolution of symptoms in the acute mTBI patients. We also did 
not correct for multiple comparisons due to the exploratory nature 
and small sample size of this study. Nevertheless, we think this 
work is an important step toward identifying the relationship of the 
antisaccade to other assessment methods used for these patients.
cOnclUsiOn
In conclusion, there were differences in antisaccade median 
latency and error mean duration between mTBI patient groups 
and controls. These measures were associated with loss of white 
matter integrity in the splenium of the corpus callosum; increased 
antisaccade median latency was also associated with poor per-
formance on executive functioning tasks and greater symptom 
load. This study adds to the existing literature suggesting that the 
antisaccade task may have potential to be useful as a neurological 
marker for acute mTBI, but with our low sample sizes and the 
exploratory nature of this study further investigation is required.
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